What This Bill Does
The Gerald E. Connolly Esophageal Cancer Awareness Act of 2025 would direct the Government Accountability Office to study esophageal cancer within the Federal Employees Health Benefits Program (FEHB). Within 1 year of enactment, the Comptroller General must report on FEHB spending tied to esophageal cancer care and on how often high-risk FEHB enrollees are screened according to established guidelines. The bill does not create a new treatment program or mandate coverage changes; it is a reporting and oversight measure focused on federal employees and retirees covered by FEHB.
- Requires a GAO report within 1 year of enactment.
- Focuses on the Federal Employees Health Benefits Program (FEHB).
- The report must estimate esophageal cancer-related health care spending for FEHB enrollees.
- The report must examine how often high-risk FEHB members are screened under established guidelines.
- The bill cites risk factors such as age 50+, smoking, obesity, and family history.
Who This Bill Affects
For a typical constituent, this bill would not directly change benefits, premiums, or eligibility. Its main effect is indirect: it could lead to better information about esophageal cancer screening and spending in the Federal Employees Health Benefits Program, which covers federal employees and retirees, and that information could shape future policy.
See how this bill affects you — sign in for a personalized analysisWho Supports & Opposes This
- Federal employees and retirees covered by FEHB They may want Congress to understand whether their health plan is identifying high-risk patients early enough and whether esophageal cancer care is driving large costs. A GAO report could expose gaps in screening and support better prevention or coverage decisions later.
- Cancer prevention advocates They are likely to support the bill because the findings stress that esophageal cancer is often detected late and that earlier screening of high-risk people can improve survival. A federal report can help quantify whether current screening practices match the risk profile described in the bill.
- Health policy researchers Researchers may favor the bill because it creates a structured federal review of spending and screening patterns in a large public workforce health program. That can provide data for evaluating whether guideline-based screening is being used consistently.
- Fiscal conservatives focused on federal oversight costs They may argue the bill adds another federal study without directly improving care, and that GAO resources should be reserved for issues with broader or more immediate policy effects. The bill does not itself reduce spending or mandate reforms.
- Federal health plan administrators Plan administrators may be wary of being scrutinized for screening rates and spending without any accompanying funding or implementation support. A report could highlight deficiencies that plans would then be expected to address later.
- Employers and benefits managers concerned about downstream mandates Some stakeholders may worry that the report is a first step toward future screening or coverage requirements that could raise utilization and costs. The bill itself does not impose those changes, but it could create pressure for them.
Key Implications
-
““submit a report to Congress ... not later than 1 year””
This creates a firm deadline for the GAO study, meaning Congress should receive the findings within a year of enactment. The report is intended to inform lawmakers relatively quickly rather than after a long research process.
-
““the total impact of esophageal cancer-related health care spending””
GAO must look at how much FEHB spends on care tied to esophageal cancer for federal employees and retirees. That could help identify whether costs are concentrated in treatment after late diagnosis.
-
““how often individuals ... who are high-risk ... undergo screening””
The bill is not just about spending; it also asks whether high-risk FEHB members are actually getting screened. That matters because the findings say early detection can improve survival and Barrett’s esophagus can be found before cancer develops.
-
““standard upper endoscopy” for people with “3 or more established risk factors””
The bill ties its screening discussion to a specific clinical approach and risk threshold. In practice, that means the report will examine whether people meeting those risk criteria are being referred for the recommended test.
-
““Federal Employee Health Benefits Program for Federal employees and retirees””
The immediate policy focus is a federal workforce health plan, not Medicare, Medicaid, or the private insurance market generally. Any direct findings will therefore apply first to FEHB enrollees, though Congress could use them in broader health policy debates.
Latest Status
May 29, 2026
Presented to President.
Take Action
Get more from BillBoard
Free tools to understand, respond to, and track this bill.
Ask AI about this billData sourced from api.congress.gov.